(Q31813959)

4 July 2017

title

Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra (English)

1 reference

4 July 2017

0 references

1 reference

1 reference

0 references

Costa G

1 reference

4 July 2017

Abin-Carriquiry JA

series ordinal

1 reference

4 July 2017

Dajas F

series ordinal

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

4 July 2017

1 reference

inferred from page(s)

published in

Brain Research

1 reference

4 July 2017

volume

888

1 reference

4 July 2017

1 reference

4 July 2017

page(s)

336-342

1 reference

Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]-chlorisondamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Differential Regulation of Neuronal Nicotinic Receptor Binding Sites Following Chronic Nicotine Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Nicotine attenuates arachidonic acid-induced neurotoxicity in cultured spinal cord neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

6-Hydroxydopamine Lesion of the Rat Substantia Nigra: Time Course and Morphology of Cell Death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Free radical-generated neurotoxicity of 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

A retrospective study of smoking in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903087-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(00)03087-0

1 reference

4 July 2017

1 reference